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Abstract
Background: Staphylococcus aureus has a high prevalence in chronic rhinosinusitis (CRS) patients and is suggested
to play a more etiopathogenic role in CRS patients with nasal polyps (CRSwNP), a severe form of the CRS spectrum
with poorer surgical outcomes. We performed a microbial genome-wide association study (mGWAS) to investigate
whether S. aureus isolates from CRS patients have particular genetic markers associated with CRS with nasal polyps
(CRSwNP) or CRS without nasal polyps (CRSsNP).
Methods: Whole genome sequencing was performed on S. aureus isolates collected from 28 CRSsNP and 30
CRSwNP patients. A mGWAS approach was employed using large-scale comparative genomics to identify genetic
variation within our dataset.
Results: Considerable genetic variation was observed, with > 90,000 single nucleotide polymorphisms (SNPs) sites
identified. There was little correlation with CRS subtype based on SNPs and Insertion/Delection (Indels). One indel
was found to significantly correlate with CRSwNP and occurred in the promoter region of a bacitracin transport
system ATP-binding protein. Additionally, two variants of the highly variable superantigen-like (SSL) proteins were
found to significantly correlate with each CRS phenotype. No significant association with other virulence or
antibiotic resistance genes were observed, consistent with previous studies.
Conclusion: To our knowledge this study is the first to use mGWAS to investigate the contribution of microbial
genetic variation to CRS presentations. Utilising the most comprehensive genome-wide analysis methods available,
our results suggest that CRS phenotype may be influenced by genetic factors other than specific virulence
mechanisms within the S. aureus genome.
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Background
The prevalence of chronic rhinosinusitis (CRS) has been
reported in the order of 10% in large epidemiological
studies [1], with a financial burden in excess of USD$20
billion in the United States annually [2]. CRS is a clinical
diagnosis defined by a constellation of symptoms lasting
> 12 weeks that include nasal blockage, obstruction,
congestion or discharge, facial pain or pressure, and
reduction or loss of smell [3]. CRS is phenotypically
subclassified into CRS with nasal polyps (CRSwNP) and
CRS without nasal polyps (CRSsNP). CRSsNP involves
fibrosis and basement membrane thickening, whereas
CRSwNP is characterized by an edematous stroma, the for-
mation of pseudocysts, and inflammatory cell infiltrates [4].
Despite recent advances in our understanding of CRS,
the etiopathogenesis of this condition remains largely
unknown [5]. Theories of CRS pathogenesis can be
broadly categorized into environmental and host related
factors [6]. The immune barrier hypothesis is the most
detailed and inclusive mechanism described in the litera-
ture. This theory proposes that a defective host mucosal
barrier and the innate immune response predispose CRS
patients to mucosal inflammation when colonized by com-
mensal bacteria that would otherwise not cause disease [7].
Central to the environmental component of the im-
mune barrier hypothesis is the role of microbes, in par-
ticular the presence of bacterial superantigens, biofilms,
intracellular bacteria and dysbiosis of polymicrobial
communities in patients with CRS. Common to many of
these hypotheses is S. aureus. S. aureus is an important
pathogen with a high prevalence in CRS patients [8] and
has been implicated in the pathogenesis of CRS through
formation of superantigens [9], biofilms [10] and cap-
acity to survive in mucosal cells [11]. S. aureus arguably
plays a more etiopathogenic role in patients with
CRSwNP, with most culture-based studies finding a
higher prevalence of S. aureus in patients with polyposis
[12]. Additionally, intracellular S. aureus and superanti-
gen production have been shown to be more prevalent
in CRSwNP patients. The role of S. aureus in promoting
polyposis is of clinical importance as CRSwNP is gener-
ally considered a more severe form of CRS with poorer
surgical outcomes.
Based on these prior studies, we hypothesized an
underlying differential virulence in S. aureus isolated
from CRSwNP patients compared to CRSsNP patients
and that this variation would have a genetic basis. To
test our hypothesis, we first investigated the distribution
of well-characterized virulence and antibiotic resistance
mechanisms to determine whether certain loci were sig-
nificantly different between these two cohorts. We then
performed a comprehensive microbial genome-wide
association study (mGWAS) using both the core and
pan-genome of 58 S. aureus isolates from CRS patients
with and without nasal polyps to determine whether
other significant genetic signatures could be identified.
Methods
Human ethics and patient inclusion criteria
The study was performed between July 2011 and August
2015 and was approved (HREC/13/TQEHLMH/277) by
the human ethics committee at the Queen Elizabeth
Hospital (Woodville, South Australia, Australia). Inclu-
sion criteria included patients with both a diagnosis of
CRS recalcitrant to appropriate medical therapy and a
positive sinus culture for S. aureus. Details of patient
age, sex, history of prior surgery, type of surgery and
diagnosis is included in Additional file 1: Table S1.
Specimen collection
Mucosal swabs and tissue from patients who underwent
surgery during the study period were collected. Culture
swabs were also taken in the postoperative period under
endoscopic guidance from areas of purulence. Caution
was exerted to avoid vestibular contamination by careful
retraction of the alar cartilage and the use of guarded
culture swabs. Specimens were referred to Adelaide
Pathology Partners (APP, Mile End, South Australia,
Australia) and processed for bacteriological culture.
Culture and DNA extraction
Bacteria were isolated on Columbia blood agar,
Columbia CNA agar, or cysteine lactose electrolyte defi-
cient agar (Oxoid, Thebarton, SA, Australia). Colonies
with S. aureus morphology were confirmed to be S. aureus
using latex agglutination testing [13]. Isolates were subcul-
tured into bovine cerebrospinal fluid broth (Thermo Fisher
Scientific, Scoresby, Australia), incubated aerobically
overnight and stored in 50% glycerol at − 80 °C. DNA was
extracted from the isolates as previously described [14].
Sequencing, genomics and biostatistical analysis
Genomic data were generated from paired-end Illumina
reads using the HiSeq 2000 platform (Illumina, Inc., San
Diego, CA, USA). Sequencing was performed at the
Australian Genome Research Facility (St Lucia, QLD,
Australia) to an average depth of ~ 150×. In silico multi-
locus sequence typing (MLST) was performed on all
genome-sequenced isolates to confirm sequence type
(ST) assignments using SRST2v0.1.8 [15], and all strains
were confirmed to be S. aureus according to a positive
nucA [16] result upon BLAST analysis. Draft assemblies
of the S. aureus genomes were constructed using an
optimized assembly pipeline of Velvet [17], PAGIT [18],
SSPACE [19] and Gapfiller [20], which have been
wrapped in MGAP [21, 22]. Draft assemblies were
annotated using Prokka v1.11 [23]. Annotated draft
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assemblies were processed with Roary v3.5.9 [24] to
create a pan-genome of all isolates included in the study.
The distribution of variably present virulence and anti-
biotic resistance loci was assessed to determine if any
significant differences existed between the CRSwNP and
CRSsNP cohorts. Virulence genes were obtained from
the Virulence Factors of Pathogenic Bacteria database
(VFDB) [25], which contained 1178 unique sequences
at the time of analysis. Antibiotic resistance genes
were obtained from the Antibiotic Resistance Gene
ANNOTation database (ARG-ANNOT) [26], which
contained 1683 unique sequences at the time of analysis.
Genes in the VFDB and ARG-ANNOT databases were
converted to amino acid sequences using EMBOSS
TRANSEQ [27]. The assembled annotated strains were
aligned against the converted databases using tBLASTn
and normalized using the large-scale BLAST score ratio
(LS-BSR) [28]. A BSR value = 0.8 approximates 80%
peptide identity over 100% of the peptide length. A BSR
value >.97 was used as the alignment threshold for analys-
ing individual genes. A BSR matrix was constructed with a
threshold score ranging between 0.85 to 0.97 to assess
association with variable gene presence using PLINK v1.9
[29]. Representative sequences with significant correlation
(Bonferroni corrected p < 0.05) were aligned to the
Microbes database of the National Center for Biotechnol-
ogy Information (NCBI) using tBLASTx to assess function.
For mGWAS, variants were identified by mapping
short read data against the draft assembly of a represen-
tative isolate within the CRSwNP group (S. aureus
DRI_4) using a combination of bwa [30], SAMTools
[31] and GATK [32], which are wrapped in the SPANDx
v3.1 pipeline [33]. Orthologous biallelic SNPs identified
by SPANDx were used as input for maximum parsimony
phylogenetic reconstruction using PAUP* v4.0a151 [34].
Matrices of orthologous and non-orthologous SNPs and
indels (SPANDx), and presence-absence regions across
the pan-genome (Roary) were used as input for mGWAS
using PLINK. Bonferroni correction for multiple testing
was applied to establish significance.
Results
Multilocus sequence typing
Among the 58 S. aureus isolates collected for this study,
23 sequence types (STs) were identified. The most
common ST was ST5 (9 isolates) followed by ST30 (8
isolates) and ST6 (5 isolates). These three STs have been
previously observed in Australian S. aureus (https://
pubmlst.org/saureus/).
Correlation of virulence genes with disease presentation
We next assessed virulence and antibiotic resistance
gene content within our dataset according to the
respective VFDB [25] and ARG-ANNOT(26)databases to
establish whether any characterized genes were associ-
ated with disease state. No significant associations were
observed with either database using a chi-squared
approach and correction for multiple testing. Similarly,
prevalence of membrane damaging toxins Hemolysins a,
b and d were similar across the study groups, being
identified in 80–100% of isolates (Table 1). Of the
bi-component toxins, the gamma toxins HlgA, HlgB and
Hlg were also identified in most isolates (96–100%),
whereas the Leukocidins were far less prevalent. The
LukS/F genes (Panton-Valentine Leukocidin) were not
identified in any isolates while the LukD/E genes were
identified in over half of the isolates. The family of serine
proteases SPL A-F, SspA (V8 protease) and ETA (ex-
foliative toxin A) were seen in varying prevalence in the
isolates studied (Table 2). The V8 protease was identified
in almost all isolates (92% CRSsNP, 96% CRSwNP) while
the SPLs were seen in 42% (SplA CRSsNP) and 76%
(SplF CSRwNP). The cysteine protease Staphopain B
(sspB) was identified in all assembled genomes. The sak
gene (Staphylokinase) (75% CRSsNP, 93% CRSwNP) was
Table 1 Distribution of Membrane Damaging Toxins in the polyp vs. non-polyp cohorts
Membrane Damaging Toxins CRSsNP CRSwNP CRSsNP (%) CRSwNP (%)
Hla hemolysin a 27 28 96% 93%
Hlb hemolysin b 28 30 100% 100%
Hld hemolysin d 27 28 96% 93%
HlgB hemolysin gamma 28 30 100% 100%
HlgA hemolysin gamma 27 30 96% 100%
HlgC hemolysin gamma 23 28 82% 93%
LUK D 16 20 57% 67%
LUK F 0 0 0 0
LUK S 0 0 0 0
LUK E 15 23 54% 77%
LUK M 0 0 0 0
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identified in a higher proportion of genomes than the coa
gene (Staphylocoagulase) (42% CRSsNP, 30% CRSwNP).
Fourteen of the known superantigen toxin genes (SEA/
B/C/G/H/I/K/L/M/O/P/Q/U/TSST) were identified in
the S. aureus isolates (Table 3). Only three superantigen
toxins were identified in > 50% of the isolates (SEG, SEM,
SEO). The remaining toxins were identified in < 25% of
genomes. Despite marked variation in the prevalence of
the various enterotoxins (3% for sek to 54–63% for seg),
no significant difference was identified across the two
isolate groups. The ICA locus genes (ICA A,B,C,D,R),
which are involved in biofilm formation, were observed
with a very high prevalence in both groups, with over 90%
of isolates carrying the gene (Table 4). The fibronectin
binding proteins FnbA/FnbB, thought to be involved in
cell wall internalisation, were observed with less preva-
lence in all groups (16–28%).
Correlation of antibiotic resistance genes with disease
presentation
The most common antibiotic resistance determinants
encoded genes for aminoglycoside resistance (Aac3-lk,
Sat4A, APH-Stph, APH-3, Spc) and phenicol (Dha1)
resistance, with these determinants found in all isolates
(Fig. 1). Tetracycline (Tet-38; 96% CRSsNP, 87%
CRSwNP), fluoroquinolone (NorA; 86% CRSsNP, 97%
CRSwNP), β-lactamase (BlaZ; 57% CRSsNP, 57%
CRSwNP) and fosfomycin (FosB; 61% CRSsNP, 67%
CRSwNP) resistance genes were also highly prevalent.
As expected, macrolide resistance genes (MphC, ErmC,
ErmA, MsrA; 18% CRSsNP, 13% CRSwNP) and the
MecA cassette for methicillin resistance (7% CRSsNP,
3% CRSwNP) were rarely identified.
Correlation of core genome variation with disease
presentation
Comparative genomic analysis identified 92,474 SNPs
and 2031 indels across the core genome of the 30
CRSwNP-derived and 28 CRSsNP-derived S. aureus
isolates. These SNPs were used to construct a
maximum-parsimony phylogenetic tree. Consistent with
the MLST results, no clear phylogenetic association was
seen in the CRSwNP or CRSsNP groups. mGWAS also
revealed no significant associations using core genome
SNPs, with all failing to reach significance level of a
Bonferroni corrected p < 0.05 (Additional file 2: Table
S2a). In contrast, one small indel in the core genome
was significantly associated with CRSwNP isolates
(Bonferroni corrected p = 0.036). This indel occurred in
the promoter region of SAOUHSC_02954 (NCTC8325
annotation), which encodes a bacitracin transport system
ATP-binding protein (Additional file 2: Table S2b). A sec-
ond indel in the accessory genome also reached significant
level; however, this variant was not found to be in a
protein-coding or promoter region.
mGWAS was also carried out on the pan-genome of the
CRSwNP and CRSsNP isolates, comprising 5978 genes. Of
these, 1783 genes were contained in the core genome while
the remaining 4015 were variable (Additional file 2: Table
S2c). Assessment of the pan-genome content for correl-
ation with disease presentation showed two genes reaching
a significance level (Bonferroni corrected p < 0.05). The first
was superantigen-like protein 5 (Bonferroni corrected
p = 0.017) and the second was superantigen-like protein
14 (Bonferroni corrected p = 0.023).
Discussion
To our knowledge, this study is the first reported
mGWAS investigating the genetics of microbes and CRS
Table 2 Distribution of toxin enzymes in the polyp vs. non-
polyp cohorts
Enzymes CRSsNP CRSwNP CRSsNP (%) CRSwNP (%)
SplB 15 20 54% 67%
SplD 18 21 64% 70%
SplF 17 23 61% 77%
SplC 19 19 68% 63%
SplE 13 13 46% 43%
SplA 12 17 43% 57%
SspB - Staphopain B 28 30 100% 100%
SspA - V8 protease 26 29 93% 97%
ETA Exfoliative Toxin A 27 29 96% 97%
Staphylokinase 21 28 75% 93%
Staphylocoagulase 12 9 43% 30%
Table 3 Distribution of superantigens (SAGs) in the polyp vs.
non-polyp cohorts
SAGs CRSsNP CRSwNP CRSsNP (%) CRSwNP (%)
SEA 5 7 17% 23%
SEB 2 4 7% 13%
SEC 4 2 14% 7%
SEG 15 19 54% 63%
SEH 4 1 14.29% 3%
SEI 16 16 58% 53%
SEK 1 1 4% 3%
SEL 4 1 14% 3%
SEM 17 17 61% 57%
SEO 17 16 61% 53%
SEP 2 3 7% 10%
SEQ 2 2 7% 7%
SEU 5 5 18% 17%
TSST 4 7 14% 23%
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phenotypes. We found considerable variation within our
S. aureus dataset, with > 90,000 SNPs identified from 23
STs and almost 6000 genes comprising the pan-genome.
Despite this variation, there were few significant associa-
tions observed between the genetic variation and CRS
phenotypes tested. One indel in the core genome of the
isolates was found to reach corrected significant thresh-
olds, while two highly variable genes were found to
reach corrected significance in the accessory genome.
Assessment of the pan-genome content for correlation
with disease presentation showed two superantigen like
toxin genes (SSL genes) that reached significance thresh-
olds. SSL5 was identified in higher prevalence in the
CRSsNP cohort, while SSL14 was more prevalent in
CRSwNP cohort. The SSL genes have been given little
attention in studies of S. aureus virulence, with a limited
Table 4 Distribution of cell wall-associated toxin proteins in the polyp vs. non-polyp cohortsa
Cell wall associated proteins CRSsNP CRSwNP CRSsNP (%) CRSwNP (%)
FNBa 12 9 43% 30%
FNBb 8 6 28.57% 20%
IcaA 28 30 100.00% 100%
IcaB 25 29 90% 97%
IcaC 27 29 97% 97%
IcaD 27 30 96% 100%
IcaR 28 29 100% 97%
aAfter Bonferroni correction for multiple testing, no toxin genes in Tables 1, 2, 3 and 4 were found to reach a significance threshold and therefore individual P values
have been omitted
Fig. 1 Gene presence-absence matrix of antibiotic resistance loci for the CRSwNP- and CRSsNP-derived S. aureus strains. Red, gene presence;
yellow, gene absence
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number of reports in the general literature and no re-
ports in rhinology research. These proteins are thought
to impede neutrophil migration and complement stimu-
lation, as opposed to T-cell activation that is commonly
associated with traditional superantigens [35, 36]. The
role of SSLs in the pathogenesis of CRS is nevertheless
unknown without functional verification.
Testing for the genetic basis of disease was first
pioneered in human genetics using genetic linkage
methods. This approach was only appropriate in specific
monogenic disorders (such as cystic fibrosis) where single
gene mutations caused the relevant disorder, with
disease causing alleles tracked though generations due to
recombination events secondary to sexual reproduction
[37]. In complex trait genetics where various genes and
environmental factors contribute to a disease phenotype,
it was not possible to use traditional approaches relying
on the principles of Mendelian inheritance. Instead, there
has been a revolution in the study of complex trait genetics
in the form of GWAS, where thousands of SNPs can be
tested simultaneously for association with disease. In
human genetics, this approach has led to the discovery of
loci associated with various human diseases that have been
subsequently targeted by novel medical therapies [38]. As
GWAS rely on large-scale comparisons (as opposed to
linkage-based analysis), it is possible to translate this work
into the field of microbial genomics [39].
The use of microbial GWAS (mGWAS) in microbial
genomics is relatively new, with the first successful
mGWAS published in 2013 [40], and other studies
published since then [41, 42]. This approach has also
recently been used to study S. aureus, with Read and
colleagues [39] identifying 121 genetic loci significantly
associated with changes in the toxicity of individual MRSA
isolates of the same sequence type (ST239) [43]. In the field
of rhinology however, all existing studies investigating the
genetics of S. aureus and CRS phenotypes have used a
“bottom-up” approach, surveying known virulence or
resistance genes across CRSwNP, CRSsNP and control
groups [44, 45]. Thunberg et al [45] used a DNA micro-
array to detect 170 distinct virulence and antibiotic resist-
ance genes in 18 CRS patients and 16 controls, finding no
significant difference in gene prevalence. Heymans et al
[44] used a similar approach but with PCR to screen for 22
exotoxin genes (enterotoxins and exfoliative toxins A and
B) in 55 CRSwNP, 16 CRSsNP and 22 control patients; they
also found no significant difference in prevalence. Investi-
gating genetic association across only a small gene panel
risks missing truly significant associations across the
genome, and it can lead to erroneous conclusions due to
linkage disequilibrium, particularly for organisms exhibiting
relatively low recombination rates like S. aureus. In
addition, gene presence/absence is only one form of genetic
variation, with SNPs and indels being potentially important
in a given phenotype. The use of mGWAS is therefore the
only feasible approach to determining whether there is a
precise genetic basis in the S. aureus genome that accounts
for different CRS phenotypes [39].
The possibility that our study has indeed identified S.
aureus point mutations or indels that causes polyp or
non-polyp disease is unlikely, due to the low level of
correlation found. Read and colleagues recently identi-
fied 121 significant loci associated with toxicity in an
mGWAS of 90 methicillin-resistant S. aureus (MRSA)
isolates. The authors selected 13 of the significant poly-
morphisms that were thought to affect toxicity, finding
that only four of these regions affected T-cell survival in
vitro when verified using transposon mutagenesis. Con-
sidering our study has only uncovered four regions of
interest (two indels and two SSL genes), it is highly likely
these associations will be false positives due to the large
number of variants tested. Future work involving in-
creased sample size may be able to detect weaker
associations not able to be elucidated in our study.
We further targeted known virulence and resistance
genes in silico, to establish the prevalence of previously
described genes and to compare this cohort with previ-
ous studies of S. aureus in CRS. Similar to the previous
literature, there were no significant differences in the
prevalence of the virulence genes tested across CRSwNP
and CRSsNP isolates [44, 45]. There was a high preva-
lence of some membrane damaging toxins (Hemolysins
a, b, d and HlgA, HlgB and Hlg), while the leukocidins
were far less prevalent, with the LukS/F genes (Panton-
Valentine Leukocidin (PVL)) not identified in any
isolates. The protease genes were seen in varying preva-
lence in the isolates studied. Fourteen of the known
superantigen (SAG) toxin genes (Sea/b/c/g/h/I/k/l/m/o/
p/q/u/TSST) were identified in the isolates with varying
prevalence. SEG, SEM and SEO (of the ECG cluster)
were the most commonly identified. The SAG’s have
been the most studied virulence genes in the CRS litera-
ture. We found similar prevalence of the most common
SAG’s reported in these studies confirming that there is
variation between the SAG’s and that the ECG cluster, is
the most ubiquitous. [44–46] In relation to cell wall
associated proteins, the ICA locus genes (ICA
A,B,C,D,R), involved in biofilm formation were observed
with a very high prevelance, of over 90% of isolates
carrying the gene. The fibronectin binding proteins
FnbA/FnbB, thought to be involved in cell wall internal-
ization, were observed with less prevalence in all groups
(from 16 to 28%). In relation to antibiotic resistance
genes, screening results were as expected, with methicil-
lin and macrolide resistance genes rare and other
antibiotic resistance genes far more common (eg. the
aminoglycoside, phenicol, tetracycline, fluroquinolone,
β-lactamase and fosfomycin resistance genes).
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There were a number of limitations inherent in this
study. Firstly, a single colony of S. aureus was selected
for sequencing from each patient, raising the possibility
that this may not be the disease-associated S. aureus
strain but rather a non-invasive commensal strain. We
did not sequence control S. aureus isolates patients in
the current study, as our hypothesis was whether there
exists an association between S. aureus virulence and
CRS phenotypes. We acknowledge that the number of
samples used in this study were modest and that a
greater number of isolates would be required to identify
a smaller effect size. Further mGWAS using all CRS
strains (CRSwNP and CRSwoNP) as a disease group and
non-CRS strains as a control group may lead to the
identification of genetic loci in S. aureus that contribute
to the pathogenesis of CRS, and should be the focus of
future mGWAS. We have not verified the significant
associations identified in this study using functional
characterisation, so inferring gene expression remains
speculative. In light of our findings, it is likely that the
spectrum of disease in CRS may be more related to host
genetics and environmental factors than a response to
specific S. aureus virulence mechanisms.
Conclusions
To our knowledge this is the first reported mGWAS
investigating the effect of microbes on CRS phenotypes.
We found considerable variation among the S. aureus
isolates from 58 patients with CRS; however, there were
minimal significant associations observed between the
CRS phenotypes tested. Utilising the most comprehen-
sive genome-wide analysis methods available, our results
suggest that CRS phenotypes may be influenced by
factors other than specific virulence mechanisms within
the S. aureus genome.
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